etidronate has been researched along with Anti-MuSK Myasthenia Gravis in 1 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sanchez-Ayaso, PA | 1 |
| Garcia-Munozguren, S | 1 |
| Salmeron, MP | 1 |
1 other study available for etidronate and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
[Ocular myasthenia revealed by risedronate].
Topics: Aged, 80 and over; Bone Density Conservation Agents; Etidronic Acid; Female; Humans; Myasthenia Grav | 2012 |